Focus on Anticoagulation Care

SORT BY:     Most Recent      Most Viewed
  • November 30, 2009

    The decision to use warfarin therapy in patients with atrial fibrillation (AF) on hemodialysis must be determined by balancing the perceived risk of thromboembolic stroke versus the risk of...

  • October 1, 2009

    A large, randomized trial involving 18,113 patients with atrial fibrillation reported that dabigatran, an investigational oral thrombin inhibitor, 150 mg twice daily was associated with lower...

  • September 14, 2009

    A population-based case–control study and a national cohort study both concluded that the risk of venous thromboembolism (VTE) is higher with oral contraceptives (OCPs) that contain progestins...

  • July 1, 2009

    A study recently published online at Circulation found that individualized low–molecular weight heparin (LMWH) bridging regimens are safe and effective in most patients on oral...

  • April 1, 2009

    Low-dose oral vitamin K does not reduce bleeding events in patients modestly over-anticoagulated with warfarin (Coumadin—Bristol-Myers Squibb), according to a study recently reported in...